by Wayne Friedman on Oct 31, 9:00 AM
If sources routinely fail to be reliable -- let's say they make over 5,000 misleading or false claims over a two-year period -- it's reasonable for journalists to shun them and look elsewhere for credibility.
by Wayne Friedman on Oct 30, 9:00 AM
Digital vMVPDs were supposed to be the savior of cable networks looking for big customer growth. Blame greater competition.
by Wayne Friedman on Oct 29, 9:00 AM
Hillary Clinton's private computer server was a bad idea, but no security was breached or crime committed. Conversely, the Russians and Chinese hacked into Trump's personal iPhone, although he's been warned not to use it.
by Wayne Friedman on Oct 26, 9:00 AM
A Russian national is the first person charged by the U.S. for conspiring to interfere in the 2018 midterms. And this wasn't her first foray into U.S. political propaganda.
by Wayne Friedman on Oct 25, 9:00 AM
Several potential pipe bombs were sent by mail to CNN's New York City headquarters, as well as the Clintons, the Obamas, the former CIA Director John Brennan, among others. All attacks were targeted to those critical of the president.
by Wayne Friedman on Oct 24, 9:00 AM
Four major TV network-based media companies have seen big changes atop their ranks when it comes to senior programming/creative executives. What's the backstory?
by Wayne Friedman on Oct 23, 9:00 AM
The combination of Disney's and Fox's library product -- TV and movies -- will total 4,000 titles. And that is more than Netflix -- once all existing licensing deals expire.
by Wayne Friedman on Oct 22, 9:00 AM
For the first time, NBC's program planning group did not have a prime-time grid to show its direct broadcast competitors where a 9 p.m. show runs against other 9 p.m. shows.
by Wayne Friedman on Oct 19, 9:00 AM
On linear TV, the average age of an "SVU" viewer is 61. But those viewing it on a digital platform? 33. For "This is Us," its linear TV average age is 55. On digital? It's 33.
by Wayne Friedman on Oct 18, 9:00 AM
Pfizer's heavily advertised nerve pain drug Lyrica has a monthly list price of $669, per reports. AbbVie's Humira, a treatment for immune system disorders like rheumatoid arthritis, carries a list price of $4,872 per monthly injection.